- On the 2nd June, the BOE (Official State Gazette) published the resolution from the 7th March this year of the General Directorate of Legal Security and Public Faith, through which it is registered in the Foundations Registry.
- The President of the “Ribera Salud” Foundation is the healthcare group’s CEO, Elisa Tarazona, and of the five members of the Board, four are doctors.
The Ribera healthcare group has established its own foundation with the aim of “contributing to the overall improvement of people’s health, quality of life and well-being” whilst “responding to the Ribera group’s social commitment to the current and future population”. This is outlined in the Official State Gazette (BOE), which today published the Resolution of the 7th March this year of the General Directorate of Legal Security and Public Faith, through which the “Ribera Salud” foundation is registered in the Foundations Registry.
The president of the Ribera Foundation is the CEO of the healthcare group, Elisa Tarazona, who is “very proud” of the corporation’s new project because it will “give a further boost to key areas for the present and future of healthcare, such as research, teaching and innovation”. She is on the Board together with Alberto de Rosa, European Executive Director of Centene and Ribera board member; Doctor Carlos Catalán, Assistant Director of the group; Doctor Javier Palau, currently Managing Director of Denia’s Department of Health, which manages the Ribera group; and Doctor Julia Camps, Corporate Director of the Breast Department. Thus, the majority of the foundation’s Board members are health professionals.
The Official State Gazette (BOE) highlights, amongst the aims of the Foundation, the desire to promote and enhance the Ribera healthcare group’s preventative, predictive, participatory, personalized and population-based medicine model. “The Foundation tries to boost innovation and create a better future, giving people the necessary tools to improve their quality of life through health management and education”, it states. Furthermore, “it is committed to cutting-edge research, including new emerging illnesses that can create pandemics”.